Search

Your search keyword '"Ethambutol administration & dosage"' showing total 441 results

Search Constraints

Start Over You searched for: Descriptor "Ethambutol administration & dosage" Remove constraint Descriptor: "Ethambutol administration & dosage" Topic tuberculosis, pulmonary Remove constraint Topic: tuberculosis, pulmonary
441 results on '"Ethambutol administration & dosage"'

Search Results

1. Early phase of effective treatment induces distinct transcriptional changes in Mycobacterium tuberculosis expelled by pulmonary tuberculosis patients.

2. Effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti-tuberculosis drugs in Chinese population.

3. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.

4. Telacebec (Q203), a New Antituberculosis Agent.

5. Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study.

6. Severe disseminated tuberculosis in HIV-negative refugees.

7. Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial.

8. Perianal ulcerative skin tuberculosis: A case report.

9. Left lung hypoplasia with a right tuberculous pleural effusion after childbirth: A case report.

10. Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial.

11. Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial.

12. Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population.

13. Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: study protocol for a prospective, multicenter, randomized, open-label, phase II trial.

14. Role of Risorine in the Treatment of Drug - Susceptible Pulmonary Tuberculosis: A Pilot Study.

15. Tuberculous cellulitis: diseases behind cellulitislike erythema.

16. Efficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial.

17. [[COMPLIANCE RATE OF STANDARD TREATMENT REGIMEN AND OPTIMAL DOSE OF ANTI-TUBERCULOSIS DRUGS IN LATE ELDERLY PATIENTS WITH PULMONARY TUBERCULOSIS].]

18. Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction.

19. Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis.

20. Pulmonary Infection Caused by Mycobacterium shinjukuense.

21. Effects on type 2 diabetes complicated with pulmonary tuberculosis: regiment of insulin, isoniazid, rifampicin, pyrazinamide and ethambutol versus the regiment plus Qi-boosting and Yin-nourishing decoction of Traditional Chinese Medicine.

22. A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.

23. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.

24. Six- vs. eight-month anti-tuberculosis regimen for pulmonary tuberculosis under programme conditions.

25. Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort study.

26. Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.

27. [Thrombocytopenia induced by rifampicin not previously sensitized: a case presentation].

28. Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis.

29. Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study.

30. Phase II dose-ranging trial of the early bactericidal activity of PA-824.

31. [Therapeutic approach in a case of allergic reaction to antituberculosis drugs -- a case report].

32. [Directly observed treatment for tuberculosis in a Buenos Aires City hospital].

33. Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis.

34. Retreatment of tuberculosis patients in the city of Porto Alegre, Brazil: outcomes.

35. Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India.

36. Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial.

37. [Sputum smear conversion during intensive TB treatment phase according to HIV status, in hospitalised patients in Togo].

38. Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA.

39. [Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003)].

40. [EVALUATION OF THE EFFICIENCY OF TREATMENT AND THE CHOICE OF CONTROL COMPUTED TOMOGRAPHY TIME IN CHILDREN WITH MINOR FORMS OF INTRATHORACIC TUBERCULOSIS].

41. Pulmonary tuberculosis presenting as fever without source in a pediatric patient with acute lymphoblastic leukemia.

42. Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.

43. Rifampicin serum levels in childhood tuberculosis.

44. Comparison of a four-drug fixed-dose combination regimen with a single tablet regimen in smear-positive pulmonary tuberculosis.

45. [Fever and thin-walled cavitary lung lesions].

46. Coccidioides immitis and Mycobacterium tuberculosis diagnosed by endoscopic ultrasound.

47. Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.

48. [Optimization of chemotherapy regimens in children with primary pulmonary tuberculosis].

49. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].

50. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].

Catalog

Books, media, physical & digital resources